Molybdenum, N,N-bis(C11-14-branched and linear alkyl)carbamodithioate oxo thioxo complexes

Skin irritation / corrosion

Administrative data

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

18 August 2017 to 16 April 2018

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2018

Report date:

2018

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test material

Test material information

Constituent 1

Reference substance name:

Bis(C11-14-branched and linear alkyl)dithiocarbamic acid

Molecular formula:

N/A

IUPAC Name:

Bis(C11-14-branched and linear alkyl)dithiocarbamic acid

Constituent 2

Reference substance name:

Molybdenum, bis(C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')oxodi-thioxothioxodi-

Molecular formula:

N/A

IUPAC Name:

Molybdenum, bis(C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')oxodi-thioxothioxodi-

Constituent 3

Reference substance name:

Molybdenum, bis(C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')dioxodi-thioxodi-

Molecular formula:

N/A

IUPAC Name:

Molybdenum, bis(C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')dioxodi-thioxodi-

Constituent 4

Reference substance name:

Molybdenum, bis(N,N-di-C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')-oxodioxo-thioxodi-

Molecular formula:

N/A

IUPAC Name:

Molybdenum, bis(N,N-di-C11-14 branched and linear alkyl)carbamodithioato-.kappa.S,.kappa.S')-oxodioxo-thioxodi-

Test material form:

liquid

Specific details on test material used for the study:

CAS RN: 906665-74-5
Purity: > 90%
Physical state/Appearance: Brown viscous liquid

In vitro test system

Test system:

human skin model

Source species:

human

Cell type:

other: reconstructed human epidermis tissues

Cell source:

other: not specified

Vehicle:

unchanged (no vehicle)

Details on test system:

Triplicate tissues were treated with the test item for an exposure period of 15 minutes. The test item was applied topically to the corresponding tissues ensuring uniform covering. 10 µL (26.3 µL/cm^2) of the test item was applied to the epidermis surface. Triplicate tissues treated with 10 µL of DPBS served as the negative controls and triplicate tissues treated with 10 µL of SDS 5% w/v served as the positive controls. The plates were kept in the biological safety cabinet at room temperature for 15 minutes. At the end of the exposure period, each tissue was removed from the well using forceps and rinsed using a wash bottle containing DPBS with Ca++ and Mg++. The rinsed tissues were transferred to the second column of 3 wells containing 2 mL of maintenance medium in each well and were incubated at 37 ºC, 5% CO2 in air for 42 hours.

MTT Loading/Formazan Extraction (Day 3)
Following the 42 hour post-exposure incubation period each 12-well plate was placed onto a plate shaker for 15 minutes to homogenize the released mediators in the maintenance medium. 1.6 mL of the maintenance medium from beneath each tissue was transferred to pre labeled micro tubes and stored in a freezer at -14 to -30 ºC for possible inflammatory mediator determination.

MTT solution, freshly prepared in assay medium, was pipetted into the third column of 3 wells of the 12-well plates. The tissues were transferred to the MTT filled wells, incubated for 3 hours at 37 °C, 5% CO2 in air, and then placed onto absorbent paper to dry. A total biopsy of the epidermis was made, the epidermis was carefully separated from the collagen matrix, and both parts (epidermis and collagen matrix) placed into labeled micro tubes containing acidified isopropanol, ensuring that both the epidermis and collagen matrix were fully immersed. Each tube was plugged to prevent evaporation, mixed thoroughly on a vortex mixer, and then were refrigerated at 1 to 10 °C until Day 6 of the experiment, allowing the extraction of formazan crystals.

Absorbance/Optical Density Measurements (Day 6)
At the end of the formazan extraction period each tube was mixed thoroughly on a vortex mixer to produce a homogenous colored solution.
For each tissue, duplicate samples were transferred to the appropriate wells of a pre labeled 96 well plate. Acidified isopropanol alone was added to the two wells designated as ‘blanks’. The optical density was measured (quantitative viability analysis) at 570 nm (without a reference filter) using the LabTech LT-4500 microplate reader.

Control samples:

yes, concurrent negative control

Amount/concentration applied:

10 µL (26.3 µL/cm^2) of the test item was applied to the epidermis surface.

Duration of treatment / exposure:

Triplicate tissues were treated with the test item for an exposure period of 15 minutes.

Duration of post-treatment incubation (if applicable):

At the end of the exposure period each tissue was rinsed before incubating for 42 hours.

Number of replicates:

Three

Results and discussion

In vitro

Results

Irritation / corrosion parameter:

% tissue viability

Value:

>= 100.3 - <= 113.3

Vehicle controls validity:

valid

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

no indication of irritation

Any other information on results incl. tables

Direct MTT Reduction

The MTT solution containing the test item did not turn blue or purple which indicated that the test item did not directly reduce MTT. Therefore, the use of water-killed tissues was not necessary

Assessment of Color Interference with the MTT Endpoint

The solution containing the test item was a brown color, therefore additional color correction tissues were incorporated into the testing procedure. However, the results obtained showed that no color interference occurred. It was therefore considered unnecessary to use the results of the color correction tissues for quantitative correction of results.

Test Item, Positive Control Item and Negative Control Item

The relative mean viability of the test item treated tissues was 106.8% (>50%) after a 15-minute exposure period and 42-hour post-exposure incubation period. It was considered unnecessary to perform the inflammatory mediator IL-1α analysis as the results of the MTT test were unequivocal. The maintenance medium that was retained for possible analysis was discarded without evaluation.

Quality Criteria

The relative mean viability for tissues treated with 5% (w/v) SDS aqueous solution (positive control) was 6.5% relative to the negative control treated tissues and the standard deviation value of the viability was 1.6% (≤18%). The positive control acceptance criteria were therefore satisfied.

The mean OD570 for the negative control (DPBS) treated tissues was 0.857, within the range of 0.6 - 1.5 and the standard deviation value of the viability was 2.6% (≤18%). The negative control acceptance criteria were therefore satisfied.

The standard deviation calculated from individual tissue viabilities of the three identically test item treated tissues was 6.5% (≤18%). The test item acceptance criterion was therefore satisfied.

Individual and Mean OD570 Values and Viabilities for the Negative Control Item, Positive Control Item and Test Item

Item	OD570 of tissues	Mean OD570 of triplicate tissues	± SD of OD570	Relative individual tissue viability (%)	Relative mean viability (%)	± SD of Relative mean viability (%)
Negative Control Item	0.838	0.857	0.022	97.8	100*	2.6
	0.851			99.3
	0.881			102.8
Positive Control Item	0.071	0.056	0.013	8.3	6.5	1.6
	0.048			5.6
	0.048			5.6
Test Item	0.890	0.915	0.056	103.9	106.8	6.5
	0.875			102.1
	0.979			114.2

The mean viability of the negative control tissues is set at 100%

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

The relative mean viability of tissues treated with the test item was 106.8%, greater than 50%, and therefore, the test item was classified as non-irritant to skin. The test item was not classified as a skin irritant according to Regulation (EC) No. 1272/2008, relating to the Classification, Labelling and Packaging of Substances and Mixtures (EU CLP).

Executive summary:

The purpose of the test was to evaluate the skin irritation potential of the test item using the EPISKIN^TMreconstructed human epidermis model after a treatment period of 15 minutes followed by a post-exposure incubation period of 42 hours. The principle of the assay was based on the measurement of cytotoxicity in reconstructed human epidermal cultures following topical exposure to the test item by means of the colorimetric MTT reduction assay. Cell viability is measured by enzymatic reduction of the yellow MTT tetrazolium salt (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) to a blue/purple formazan salt (within the mitochondria of viable cells) in the test item treated tissues relative to the negative controls. The study was performed to the standardised guidelines OECD 439 and EU Test Method B. 46., under GLP conditions.

 

Triplicate tissues were treated with the test item for an exposure period of 15 minutes. At the end of the exposure period each tissue was rinsed before incubating for 42 hours. The test item was found to have the potential to cause color interference with the MTT endpoint therefore additional tissues were incorporated into the testing to correct for this. At the end of the post-exposure incubation period each tissue was taken for MTT-loading. The maintenance medium from beneath each tissue was transferred to pre-labeled micro tubes and stored in a freezer for possible inflammatory mediator IL-1α determination. After MTT-loading a total biopsy of each epidermis was made and placed into micro tubes containing acidified isopropanol for extraction of formazan crystals out of the MTT-loaded tissues. At the end of the formazan extraction period each tube was mixed thoroughly and duplicate 200 μL samples were transferred to the appropriate wells of a pre-labeled 96-well plate. The optical density was measured at 570 nm.

Data has been presented in the form of percentage viability (MTT reduction in the test item or positive control treated tissues relative to negative control tissues).

 

The relative mean viability of the test item treated tissues was 106.8% after the 15-minute exposure period and 42-hours post-exposure incubation period.

 

The relative mean viability of tissues treated with the test item was 106.8%, greater than 50%, and therefore, the test item was classified as non-irritant to skin. The following classification criteria apply: The test item was not classified as a skin irritant according to Regulation (EC) No. 1272/2008 Classification, Labelling and Packaging of Substances and Mixtures (EU CLP).